Recent Updates
Recently added Catalysts
TRIB Positive Sentiment Score: 65/100

Trinity Biotech plc to Host Investor Call

Tuesday, January 30, 2024 1 min read
Key Takeaway: Trinity Biotech plc will host an investor call on January 31, 2024, at 8:30 AM ET to provide an update on its business operations. The company specializes in diagnostic solutions for point-of-care and clinical laboratory markets. This call aims to engage with investors and share insights into current performance and future prospects. As a leading manufacturer in the medical diagnostics field, Trinity Biotech operates in multiple countries across the globe.

Market Sentiment Analysis

POSITIVE FACTORS

  • Trinity Biotech is providing a business update, which may indicate growth or positive developments.
  • The company is actively engaging with investors, signaling transparency and communication.
  • Trinity Biotech's focus on diagnostics positions it well in a growing healthcare market.

Full Press Release Details

DUBLIN, Ireland, Jan. 30, 2024 (GLOBE NEWSWIRE) -- Trinity Biotech plc (Nasdaq: TRIB) (the “Company”), a leading developer and manufacturer of diagnostic solutions for the point-of-care and clinical laboratory markets, will host an investor call on Wednesday, January 31 at 8:30 AM ET to provide an update on business operations.
Conference Call Dial-In & Webcast Information
Date: Wednesday, January 31, 2024
Time: 8:30 AM ET
United States: 1-877-407-0784
International: 1-201-689-8560
Conference ID: 13744109
Webcast: Click Here for Webcast
CallMe™: Click Here for CallMe Feature
About Trinity Biotech
Trinity Biotech develops, acquires, manufactures and markets diagnostic systems, including both reagents and instrumentation, for the point-of-care and clinical laboratory segments of the diagnostic market. The products are used to detect infectious diseases and to quantify the level of Haemoglobin A1c and other chemistry parameters in serum, plasma and whole blood. Trinity Biotech sells direct in the United States, Germany, France and the U.K. and through a network of international distributors and strategic partners in over 75 countries worldwide. For further information, please see the Company's website: www.trinitybiotech.com.

Frequently Asked Questions

When will Trinity Biotech host its investor call?

Trinity Biotech will host its investor call on January 31, 2024, at 8:30 AM ET.

How can I join the Trinity Biotech investor call?

You can join by dialing 1-877-407-0784 in the U.S. or 1-201-689-8560 internationally.

What is the purpose of the investor call?

The investor call aims to provide an update on Trinity Biotech's business operations.

What type of products does Trinity Biotech develop?

Trinity Biotech develops diagnostic systems for infectious diseases and chemistry parameters.

In which countries does Trinity Biotech sell its products?

Trinity Biotech sells directly in the U.S., Germany, France, and the U.K., and globally.

Tags: TRIB Viatris Investor Conferences Healthcare Trinity Biotech investor call diagnostic solutions healthcare
Last updated: Jan 30, 2024